EVENTS · LMAT
PEERS
EARNINGS
| Series | 1W | 1M |
|---|---|---|
| LMAT | +6.1% | +11.2% |
| Peers | +5.0% | +12.4% |
| Sector · Health Care | +5.6% | +13.5% |
| SPY | −0.7% | −1.6% |
| Percentile rank vs S&P 500 | 59 | 61 |
LeMaitre Vascular Reports Q3 2026 Sales of $68.0 Million
| QUARTER | EPS EST | EPS ACTUAL | EPS SURPRISE | REACTION |
|---|---|---|---|---|
| Q3 FY2026 | 0.69 | 0.65 | −5.80% | — |
| Q2 FY2026 | 0.82 | 0.74 | −10.07% | −23.75% |
| Q1 FY2026 | 0.67 | 0.68 | +0.86% | −1.17% |
| Q4 FY2025 | 0.68 | 0.68 | +0.41% | +25.28% |
| Q3 FY2025 | 0.58 | 0.62 | +7.38% | +0.64% |
| Series | 1W | 1M |
|---|---|---|
| LMAT | +6.1% | +11.2% |
| Peers | +5.0% | +12.4% |
| Sector · Health Care | +5.6% | +13.5% |
| SPY | −0.7% | −1.6% |
| Percentile rank vs S&P 500 | 59 | 61 |